share_log

NexImmune | SEC STAFF LETTER: Others

SEC ·  Feb 17, 2021 03:09
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.